This federal contract award, with an ID of SPE2DB20D2014|SPE2DB25FA68G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $94,834.62 fixed-price delivery order contract is for the supply of SKYRIZI 150 MG/ML PENML, a medical product, with a period of performance ending on January 2, 2025.
The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 10:55 AM